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1. Introduction
  Drug-delivery applications utilize bioadhesive 
macromolecules to localize treatment to a specific area 
of the body, thereby increasing the residence time and 
improving the oral bioavailability[1]. For intravascular 
applications, a targeting agent such as a ligand is 
incorporated into the drug-delivery system, creating 
adhesion through the ligand-receptor interaction present 
at the endothelium surface. Bioadhesion in this instance is 
governed by (i) the shear stress caused by the hemodynamic 
force exerted over the cell/ particle, (ii) the loading 
rate which is affected by the viscosity of the biological 
environment and (iii) the ligand/receptor density ratio which 
can be controlled during the fabrication of the system[2]. For 
oral drug-delivery systems, mucoadhesion is the specific 
type of bioadhesion responsible for localizing the system 
at the mucous gel layer, which lines the absorptive regions 
of the alimentary canal. Polymers that have typically been 
utilized in the development of mucoadhesive controlled 
release formulations include hydrophilic macromolecules 
containing numerous hydrogen bonding groups such as 
polymethacrylic acid[3]. Dosage forms have been engineered 
so that they take advantage of the abilities to molecularly 
design polymer networks to impart specific structural 
characteristics so that polymers comprising the dosage form 
are multifunctional. This new generation of bioadhesives 
has employed hybrid materials such as lectins, fimbrial 
proteins, or ligands which have specific interaction sites 
within the body.  It was discovered that there was no report 
on the effect of polyethylene glycol (PEG) on mucin in any 
form either as drug deliver or on the bioadhesive property; 
hence this study was carried out to evaluate the effect 
of PEG on the bioadhesive property of mucin as a drug 
delivery system
2. Materials and methods
2.1. Extraction of snail mucin (slime)
  After procurement, the shells of the giant African land 
snails were knocked open at the apex and a spirally coiled 
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rod inserted to remove the fleshy body from where the 
excretory parts were removed.  The fleshy parts were then 
placed in 250 mL of water and washed several times until the 
(slime) mucin was completely washed off. These washings 
were pooled together in a plastic bucket, precipitated 
with chilled acetone and lyophilized in a lyophilizer. The 
greyish-brown lyophilized flakes of the snail mucin were 
pulverized into fine powder using a mortar and pestle and 
stored in an airtight container until use.  
2.2. Preparation of PEGylated-mucin
  Mucin and PEG were mixed in the following ratios: 1:1, 
2:1, 1:2, 0:1, 1:0 to form batch (A-E). A known quantity of 
mucin and polyethylene glycol were weighed and put in a 
separate 100 mL baker. 20 mL of solvent (water) were added 
into the sample and allowed to stand for 72 h, these is to 
allowed complete interaction of the solvent and the different 
polymer. The baker that contained polyethylenglycol was 
later mixed with the hydrated mucin in a baker and allowed 
to stand for another 72 h to form a single polymer after 
allowing for molecular interaction and bonding formation 
to take place. The mixture was precipitated with chilled 
acetone. The precipitate were collected, dried, pulvirised 
and kept in a tight container until used. The same method 
was applied to all the batches.
2.3. Physicochemical and organoleptic properties of snail 
mucin
  A small quantity of the powdered mucin was subjected to 
physiochemical tests using established standard procedures 
for the determination of proteins, carbohydrates, fats and 
oil[4]. The physical characterisation of the mucin was carried 
out using a small quantity of the mucin sample as described 
in our previous studied[5].
2.4. Preparation of drug bioadhesive tablets 
  Batches of Vernonia amygdalina aqueous extract tablets 
were produced using the different ratios of the PEG: mucin 
as polymers. Wet granulation method of tablet production 
was employed and the granules compressed in a tablet press 
(F3 Manesty) with a force of 48 kgf. The ratio of polymers 
used for the different batches are stated in Table 1, together 
with the amount of drug used.
 
 
2.5. Determination of the matrix micromeretics
2.5.1. Flow rate and angle of repose
  The funnel method described by Carstesen and Chan[6] 
was employed to measure the flow rate of the matrices. A 
5.0 g quantity of the respective matrices was introduced into 
a plastic funnel with the following parameters: efflux tube 
length of 5.5 cm, funnel diameter measured from bottom of 
efflux tube of 7 cm, diameter of funnel at top 5.8 cm and 
diameter of efflux tube 0.6 cm. 
 The matrices were allowed to fall freely into weighed 
clean pieces of papers that serve as collector, whose areas 
have been established.  The flow times were noted and the 
resulting height of the heap (h), were measure using meter 
rule.  The diameter (d), of the base of the heap was also 
measured. The flow rate was calculated using the following 
equation:
Mass(g)
Flow times(s)
F=                           ……………………Eqn.1  
The angle of repose, Ø, was calculated from Eqn. 2   
h
0.5d
Tan Ø=             ……………………Eqn.2
2.5.2. Bulk and tapped densities
  A 5 g quantity of the granules was introduced into a clean 
25 mL calibrated measuring cylinder calibrated in cm
3. The 
volume of the matrices was read directly from the calibrated 
cylinder without tapping. The cylinder was then tapped from 
a constant height 25 times and the tapped volume was then 
read. The bulk (Db) and tapped densities (Dt) were expressed 
in g/mL. The compressibility index of the matrices was also 
determined.
Mass
Flow volume
Db=                             (kg.m
-3) ……………………Eqn.3
Mass
Flow volume
Dt=                             (kg.m
-3) ……………………Eqn.4
2.2.7.3   Hausner’s quotients
  Hausner’s quotients (HQ) and percentage compressibility 
index (PC) were calculated ( Vb = bulk volume and Vt = 
tapped volume)  using the following equations: 
Dt
Db
HQ=             ……………………Eqn.5  
Vb-Vt
Vb
PC=              伊100 ……………………Eqn.6
2.5.3. Tensiometric bioadhesive test  
  A tensiometer (Lecomte Du Nuoy Tensiometer, Model Nr 
3124, A. Kruss Germany) was used for the study. Hog ileum 
of about 5 cm long and 2 cm wide was longitudinally slit to 
expose the mucus surface. The ileum was pinned on a cork 
placed on the metal support of the tensiometer. A flexible 
constantan wire on which a plastic plate at width of 2 cm was 
attached and hung at the place meant for it on the lever. The 
plastic plate was made to gently touch the intestinal mucus 
surface. The plate was thereafter raised by means of a screw 
until it just detached from the surface of the mucus. The 
tension required for this was read off. Some weight was used 
to return the lever back to zero and the weight determined.
  One tablet from each batch was glued to the plastic plate 
of the tensiometer using a cyanocrylate adhesive. The plate 
with the tablet was then hung on the lever which was then 
Table 1
Ratios and quantities of the polymers used in tableting (mg/kg). 
Batches  Ratios
Amount  of polymer
DrugPolyethylene 
glycol 
Snail mucin
A 1:1 25 25 2.5
B 2:1 50 25 2.5
C 1:2 25 50 2.5
D 0:1 0 25 2.5
E 1:0 25 0 2.5
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zeroed. The hog ileum on the metal support was raised to 
establish contact with the glued tablet. A time interval of 5 
min was allowed for tablet mucus interaction. Thereafter, 
the plate was raised by means of a screw until the tablet just 
detached from the surface of the mucus layer. The tension 
required for the tablets removal was read off from the 
tensiometer in degrees. An average of three determinations 
was recorded. The procedure was repeated for all the tablet 
batches. The respective averages in degrees were thereafter 
converted to tension equivalent of bioadhesive strength 
using the formula below:
mg
2L
T=              伊F ……………………Eqn.7
  Where T = tension, m = weight in kg, g = acceleration due 
to gravity (10 m/s
2), L= perimeter of the plastic plate, F= 
constant =0.94.
    
3. Results
  The results of the studies are shown in Tables and 
Figure 1 below. The characterisation carried out on snail 
mucin shows that carbohydrate, protein and fats were the 
predominant composition of the mucin as presented in Table 
2, while the bulk volume, tapped volume, bulk density and 
true density of the PEGylated matrices were determined. 
Other characterisation such as angle of repose, Hausner’s 
quotients, flow rate and % compressibility were similarly 
assessed. All tests were done in triplicates. The bioadhesive 
properties of the PEGylated matrices on SIF and SGF are 
shown in (Figure 1)
Table 2   
Physicochemical properties of snail mucin.   
Test Observation Inference
Carbohydrate + + + + + Present
Protein + + + Present
Fats + Present
+ Present in trace amount; + + + + Copiously present
Figure 1.  Bioadhesive strength of mucin / polyethylene glycol 
matrices in SIF and SGF.
Table 3
 Physical properties of  the matrices are shown below. 
Properties 
Ratios  of mucin : polyethylene glycol 
1:1 2:1 1:2 0:1 1:0
Bulk vol. (cm3)  10.00依 0.70  10.80依0.10 11.50依0.50 10.90依1.20   12.20依1.50
Tapped vol. (cm3)     8.90依20.50      8.80依20.50   10.20依2 0.50     8.80依20.75   10.20依2.50
Bulk density (g/ cm3)    0.50依21.50     0.46依20.25   0.43依21.20      0.49依2 0.75     0.41依0.50
True density  (g/ cm3)     0.56依20.55     0.57依21.50  0.49依22.10     0.61依21.50     0.49依2.00
Compressibility (%)   11.00依22.50   18.50依22.50 11.30依2 0.35   19.20依21.50     16.40依20.25
Angle of repose Ø 35 31 30 33 33
Flow rate (sec)    3.00依20.00   3.00依20.10   2.0依21.10    4.00依22.50      3.50依20.50
Hausner’s Quotients    1.12依22.00   1.24依20.25 1.14依21.50    1.25依20.75      1.20依20.35
Note: Results are the means of 3 measure依0.5 SD.
4. Discussion 
  Results of some physiochemical tests performed on the 
snail mucin shows that carbohydrates, proteins and trace 
amounts of fats were predominant composition of the 
mucin. Physical characterisation of mucin both wet and dry 
states shows that mucin is light-brownish in colour, almost 
tasteless and has a pleasant meaty odour. 
  The physical properties of the co-polymer matrices are 
presented in the result part. The range of flow rates of the 
matrices was 1.35-2.23 g/sec. The angle of repose, which 
indirectly quantifies powder flowability and relates to inter-
particles cohesion[7] was in the range of 37.3-39.9 degree. 
This obviously indicated that the matrices have good 
flowability properties. The bulk and tapped densities were 
within the ranges of 0.41-0.49.  The Hausner’s quotient (HQ) 
were 1.12,  1.24, 1.14, 1.25 and 1.2 for matrix batches A-E 
respectively. These show that A, C and E were within the 
accepted  range for  Hausner’s  quotients(HQ), while B and 
D were slightly above the range. Studies have shown that 
values approximate to 1.2 indicate good characteristics for 
a powder[8]. The percentage compressibility (PC) values of 
the co-polymer matrices A- E were 11.0, 18.5, 11.3, 19.2 and 
16.4 respectively. Studies have proved that material having 
PC values of  5-15, 12-16 and 18-21% have excellent, very 
good and fair flow behaviours respectively[9]. The result 
obtained in this characterisation is an indication that, 
matrices A and C have an excellent properties, E has very 
good while B and D have fair flow behaviours.
  The main aim of this bioadhesive study was to evaluate 
the effect of the co-polymer matrices on the mucosal wall 
and to see the impact of mucin on the bioadhesive property 
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of PEG as compared to the individual polymer on the fluid 
environment (SGF and SIF). The result showed that the 
bioadhesive strength of the tablets formed with the various 
PEG and mucin ratio increased as the mucin concentration 
increased in the formulations, for all the media used. 
The highest mucoadhesive strength of 120.0伊10-5 N was 
observed in the formulations that contained mucin : PEG 
(2:1) of 120.0 伊10-5 N in SGF followed by 116.0伊10-5 N  in 
SIF, but was least for tablets prepared with polyethylene 
glycol (0:1). The order of the bioadhesive strengths was 
as follows: 2:1 > 1:1>1:0> 1:2> 0:1 in both SIF and SGF. 
For bioadhesion to occur, a succession of phenomena, 
whose role depends on the nature of the bioadhesive 
material, is required. The first stage involves an intimate 
contact between a bioadhesive and a membrane, either 
from a good wetting of the bioadhesive surface, or from 
the swelling of the bioadhesive. In the second stage, after 
contact is established, penetration of the bioadhesive into 
the crevices of the tissue surface or inter penetration of the 
chains of the bioadhesive with those of the mucus takes 
place. Low chemical bonds can then settle. On a molecular 
level, mucoadhesion can be explained based on molecular 
interactions. The interaction between two molecules is 
composed of attraction and repulsion. Attractive interactions 
arise from Van der walls forces, electrostatic attractions, 
hydrogen bonding and hydrophobic interactions. Repulsive 
interactions occur because of electrostatic and steric 
repulsion[10]. For mucoadhesion to occur, the attractive 
interaction should be larger than non -specific repulsion[11]. 
Study has shown that mucoadhesive dosage forms that can 
stick to the site of application/absorption have attracted 
considerable interest since the idea was first introduced 
early in the 1980s[12]. The advantages of mucoadhesive 
formulations include, prolonged residence time at the site 
of drug absorption and better contact with the underlying 
mucosa so that the diffusional path of the drug to the 
epithelium is shorter. Furthermore, some mucoadhesive 
polymers can modulate the permeability of epithelial cells 
by partially opening tight junctions[13].  Recent researche 
have shown that nanoparticles coated with low molecular 
weight (MW) PEG possess hydrophilic and near neutrally-
charged surfaces that minimize mucoadhesion by reducing 
hydrophobic or electrostatic interactions[14]. These coatings 
were inspired by viruses with similar surface properties that 
are capable of moving rapidly through human mucus[15]. 
However, a vast amount of literature has shown that PEG 
can be strongly bioadhesive, presumably by interpenetrating 
polymer network (IPN) effects between PEG chains and 
the mucus mesh[16] and/or hydrogen bonding between 
ether oxygen atoms in PEG and sugars on glycosylated 
mucin[17].  Research has shown that PEG is a biocompatible 
polymer that has enjoyed widespread use in drug delivery 
technology, it is considered adhesive toward mucosal tissue, 
Here the author described a simple approach to enhancing 
mucoadhession of PEG polymers through end group 
functionalisation with the amino acid 3,4-dihydroxyphenyl- 
L- alanine (DOPA) using a variety of surface analytical 
methods[18]. The finding from our study is in line with the 
above as, our PEG-mucin showed a better bioadhesion than 
when the polymer were used individually in both SIF and 
SGF. The study here suggested that the PEGylated-mucin 
matrices may be a promising candidate for oral controlled 
drug delivery system because of its bioadhesive forming 
ability and sustaining the release of drug in contact with the 
mucosa wall of the intestine.
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